Back to company

Nordic Pharma Lab ApS: Financial statements 2018

CVR: 39161672

Nordic Pharma Lab ApS (CVR 39161672) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -11,340 and a net result of DKK -11,340. Equity amounted to DKK 88,660. The solvency ratio was 92.2%.

Gross Profit
-11,340 kr.
Profit/Loss
-11,340 kr.
Equity
88,660 kr.
Total Assets
96,160 kr.

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on Nordic Pharma Lab ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2018

ApS STM nr. 6145 changes name to Nordic Pharma Lab ApSJan 11, 2018

On January 11, 2018, the company changed its name from ApS STM nr. 6145 to Nordic Pharma Lab ApS.

About Nordic Pharma Lab ApS

Nordic Pharma Lab ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2017. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named ApS STM nr. 6145. The management consists of Torsten Bjørn. The company's owners include TT 1919 ApS, Beier Holding ApS and FINANSMANAGEMENT ApS. In 2025, the company reported a gross profit of DKK -52,093 and a net result of DKK -110,916 compared with DKK -30,573 the year before. Equity amounted to DKK -429,426.

Other financial years